Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -8.00 (-3.48%)
Bid:
215.00
Ask:
227.00
Spread: 12.00 (5.581%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Trading Update and Board Changes

22 Oct 2015 07:00

RNS Number : 0335D
Microgen PLC
22 October 2015
 



microgen

www.microgen.com 22 October 2015

 

 

MICROGEN PLC

("MICROGEN" or "GROUP")

 

TRADING UPDATE AND BOARD CHANGES

 

 

Trading Update

 

The Group's Aptitude Software and Financial Systems businesses continue to perform in line with the Board's expectations. Consistent with this stage of the financial year, 95% of total expected revenue for 2015 is now contracted. High forward revenue visibility is a benefit of the Group's annual licensing model.

 

Appointments and Board Structure

 

Microgen is pleased to announce the appointment of Ivan Martin to the Board. Mr Martin will initially join the Board as a Non-Executive Director and Chairman Designate on 1 January 2016 before assuming the role of Non-Executive Chairman after the release of the 2015 Results.

 

Mr Martin (60) will chair the Nomination Committee and be a member of the Audit and Remuneration Committees. Mr Martin is currently Non-Executive Chairman of both FDM Group plc and Red Topco Limited (trading as Red), a specialist SAP-based IT services business. Previously Mr Martin was a member of Misys plc's board and headed their banking software division until 2005. Between 2007 and 2013, he was Executive Chairman of Sesame Bankhall Group and Non-Executive Director of Avelo.

 

The Managing Directors of the Group's two operating businesses have been attending Board Meetings by invitation since 2013 and will formally join the Board on 1 January 2016. Simon Baines (44) joined Microgen in 2010 as Managing Director of the Financial Systems business, prior to which he worked in private equity covering financial services technology companies. Tom Crawford (47) joined Microgen in 2003 and was appointed Head of Aptitude Software USA operations in 2010 before being promoted to Managing Director of Aptitude Software in 2013, a role that divides his time between Boston and London.

 

Martyn Ratcliffe, will step down as Chairman and as a Director after the release of the 2015 Results allowing a smooth transition to Mr Martin.

 

Regulatory Information - Ivan Martin

 

As at 21 October 2015 Mr Martin does not currently have any interest in any ordinary shares in Microgen. Mr Martin is Non-Executive Chairman of FDM Group plc.

 

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13R relating to the appointment to the Board of Mr Martin.

 

Regulatory Information - Simon Baines

 

As at 21 October 2015 Mr Baines is the beneficial owner of 9,523 ordinary shares in Microgen and has an interest in 650,000 unvested share options.

 

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13R relating to the appointment to the Board of Mr Baines.

 

Regulatory Information - Tom Crawford

 

As at 21 October 2015 Mr Crawford is the beneficial owner of 129,551 ordinary shares in Microgen and has an interest in 650,000 unvested share options.

 

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13R relating to the appointment to the Board of Mr Crawford.

 

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

Philip Wood, Group Finance Director

 

Rowena Murray, Investec 020-7597-5970

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLRIVLLFIE
Date   Source Headline
11th Apr 20163:50 pmRNSHolding(s) in Company
30th Mar 20163:55 pmRNSBlocklisting Interim Review
30th Mar 20163:52 pmRNSTotal Voting Rights
22nd Mar 201610:07 amRNSHolding(s) in Company
21st Mar 20164:18 pmRNSHolding(s) in Company
15th Mar 20164:41 pmRNSHolding(s) in Company
15th Mar 20164:34 pmRNSHolding(s) in Company
15th Mar 20164:30 pmRNSHolding(s) in Company
14th Mar 201612:51 pmRNSHolding(s) in Company
3rd Mar 20167:00 amRNSPreliminary Results
26th Jan 20167:00 amRNSBusiness Update & Notice of Results
14th Jan 20163:29 pmRNSBlocklisting Interim Review
7th Jan 20169:39 amRNSHolding(s) in Company
29th Dec 20159:17 amRNSHolding(s) in Company
5th Nov 201510:12 amRNSProperty Disposal
2nd Nov 201510:10 amRNSHolding(s) in Company
29th Oct 20155:21 pmRNSHolding(s) in Company
27th Oct 20154:14 pmRNSHolding(s) in Company
27th Oct 201510:00 amRNSTotal Voting Rights
22nd Oct 201512:29 pmRNSDirector/PDMR Shareholding
22nd Oct 20157:01 amRNSDirector/PDMR Shareholding
22nd Oct 20157:00 amRNSTrading Update and Board Changes
29th Sep 20157:01 amRNSBlocklisting Interim Review
28th Aug 20159:52 amRNSTotal Voting Rights
22nd Jul 20155:46 pmRNSBlocklisting return
16th Jul 20157:02 amRNSInterim Results
16th Jul 20157:00 amRNSAcquisition of Jobstream Group Limited
15th Jul 20151:22 pmRNSNotice of Results
9th Jun 20157:00 amRNSAcquisition
18th May 20159:58 amRNSResult of AGM
18th May 20157:00 amRNSAGM Trading Update
29th Apr 201512:26 pmRNSHolding(s) in Company
30th Mar 20155:49 pmRNSBlocklisting Interim Review
19th Mar 20157:00 amRNSReturn of Value and Listing of New Ordinary Shares
18th Mar 201511:23 amRNSResults of General Meeting
6th Mar 201512:22 pmRNSHolding(s) in Company
26th Feb 20153:39 pmRNSHolding(s) in Company
25th Feb 20152:26 pmRNS2014 Final Dividend
25th Feb 20157:02 amRNSReturn of Value
25th Feb 20157:01 amRNSPreliminary Results
28th Jan 20152:02 pmRNSHolding(s) in Company
23rd Jan 20151:17 pmRNSHolding(s) in Company
23rd Jan 20157:00 amRNSTrading Update
21st Jan 201512:14 pmRNSDirector Declaration
5th Jan 20157:00 amRNSBlocklisting Interim Review
5th Dec 20147:00 amRNSAcquisition
3rd Nov 20147:00 amRNSTotal Voting Rights
30th Oct 20147:00 amRNSInterim Management Statement
7th Oct 20142:28 pmRNSAdditional Listing
30th Sep 20142:47 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.